{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-002078","form_type":"8-K","ticker":"AURX","cik":"0001091596","company_name":"Nuo Therapeutics, Inc.","filed_at":"2026-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.526584+00:00","generated_at":"2026-05-16T07:48:45.481280+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuo Therapeutics secures up to $1.6M loan with 10%-12% PIK interest paid in warrants; insider participation","bullets":["Loan agreement for $1.0M initial + $600K second tranche (Sept 30, 2026); $1.0M funded Jan 23, 2026.","Interest 10% annual on initial note, rising to 12% if second tranche is taken; accrued interest paid only in warrants at maturity.","Principal repaid in 8 equal quarterly installments from Mar 31, 2027 to Dec 31, 2028; early prepayment fee 1.5-2.75% of principal paid in warrants.","Lenders include director/10% owner Scott Pittman ($200K) and >5% owner Paul Jacobs ($300K); each received initial and potential second warrants.","Warrants exercisable at $1.50/share, expiring Jan 23, 2031; up to 226,000 interest warrant shares issuable at maximum borrowing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-002078","json":"https://secwatch.observer/filing/0001437749-26-002078.json","markdown":"https://secwatch.observer/filing/0001437749-26-002078.md","text":"https://secwatch.observer/filing/0001437749-26-002078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002078/0001437749-26-002078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002078/aurx20260122_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T07:48:45.481280+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f847e75eee5a6912c4d64db71cc20d15cc22f93d","claim":"Nuo Therapeutics, Inc. incurred credit facility of aggregate principal amount of up to $1.6 million with four lenders (including Scott M. Pittman and Paul Anthony Jacobs) at annual rate of 10% maturing December 31, 2028.","evidence_excerpt":"On January 21, 2026, Nuo Therapeutics, Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan Agreement”) with four lenders (collectively, the “Lenders”). The Loan Agreement provides for loans in an aggregate principal amount of up to $1.6 million with (a) $1.0 million funded on the initial closing date (the “Initial Funding”) and (b) $600 thousand to be funded, if requested in advance by the Company and subject to closing conditions, on September 30, 2026 (the “Second Funding”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002078/0001437749-26-002078-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"aggregate principal amount of up to $1.6 million"},{"label":"Counterparty","value":"four lenders (including Scott M. Pittman and Paul Anthony Jacobs)"},{"label":"Rate","value":"annual rate of 10%"},{"label":"Maturity","value":"December 31, 2028"},{"label":"Event","value":"incurrence"}]},{"claim_id":"204dd91196a3a6669ebb5f01235d860d9db485d6","claim":"Nuo Therapeutics, Inc. entered into Loan and Security Agreement with four lenders (collectively, the \"Lenders\") valued at up to $1.6 million (effective 2026-01-21).","evidence_excerpt":"On January 21, 2026, Nuo Therapeutics, Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan Agreement”) with four lenders (collectively, the “Lenders”). The Loan Agreement provides for loans in an aggregate principal amount of up to $1.6 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002078/0001437749-26-002078-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"four lenders (collectively, the \"Lenders\")"},{"label":"Value","value":"up to $1.6 million"},{"label":"Effective","value":"2026-01-21"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}